| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-200c | Paclitaxel | endometrial cancer | Sensitive | Low | 19435871 | |
| miR-200c | Paclitaxel | ovarian cancer | Sensitive | Low | 21051560 | |
| miR-200c | Paclitaxel | gastric cancer | Sensitive | Low | 21114921 | |
| miR-200c | Paclitaxel | prostate cancer | Resistant | Low | 22768203 | |
| miR-200c | Paclitaxel | ovarian cancer | Sensitive | Low | 23074172 | |
| miR-200a | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-200b* | Paclitaxel | laryngeal cancer | Resistant | High | 23826416 | |
| miR-200b | Paclitaxel | melanoma | Sensitive | Low | 25138213 | |
| miR-200a | Paclitaxel | ovarian cancer | Sensitive | Low | 25997962 | |
| miR-200 | Paclitaxel | ovarian carcinoma | Resistant | Low | 26025631 | |
| miR-200c | Paclitaxel | lung adenocarcinoma | Sensitive | High | 26323677 |